Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This trial is an open-label, multi-center, parallel-arm, single-dose trial in 2 groups: 1
group of subjects with normal renal function and 1 group of severely renally impaired
subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.